Clinical Trial Update: A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating GWP42004 as add-on therapy to metformin in type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GWP42004

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED